RIO DE JANEIRO, BRAZIL - The Federal Supreme Court (STF) has ruled that it is the State's duty to supply drugs that, although not registered with the Brazilian Health Regulatory Agency (ANVISA), have their importation authorized by the body.
The Court's ruling is applicable whenever the patient proves economic incapacity, the indispensability of the treatment, and the impossibility of replacing it for another drug provided by the National Health System (SUS).
The decision was reached in an online session closed on June 18, with the ruling becoming a "general repercussion" case, i.e. one . . .